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The study indicates that significant savings can be made by using single-use bronchoscopes to guide percutaneous dilatational tracheostomy (PDT) in preference to reusable bronchoscopes.Estimated cost savings associated with the use of single-use bronchoscopes was \$US157 per PDT procedure.Our findings are associated with a certain degree of uncertainty due to the increased variances in the findings from the literature.

Introduction {#Sec1}
============

Tracheostomy involves the creation of an artificial stoma between the trachea and the anterior neck. Whilst classically performed as an open surgical procedure by head and neck surgeons to relieve actual or threatened airway obstruction, around two-thirds of tracheostomies are currently performed by intensive care unit (ICU) clinicians on critically ill patients. The majority of these procedures are performed to facilitate weaning from prolonged mechanical ventilation \[[@CR2]\]. Percutaneous dilatational tracheostomy (PDT) is an alternative tracheostomy insertion technique that can be performed at the bedside, and is an attractive option when considering the practical and logistical challenges of moving a critically ill patient to an operating theatre \[[@CR3], [@CR4]\]. The PDT technique was described by Ciaglia in 1985, and has subsequently become widely used as a practical, safe and cost-effective alternative to open surgical tracheostomy \[[@CR3]--[@CR6]\]. The procedure involves the insertion of a needle through the skin of the anterior neck into the trachea, followed by the insertion of a guidewire. Using a 'Seldinger technique', serial dilators are then guided into the trachea via the guidewire to create the stoma before the tracheostomy tube is finally inserted \[[@CR3]--[@CR7]\].

PDT is usually performed with bronchoscopic guidance to visualise the trachea during the insertion process \[[@CR2], [@CR7]--[@CR9]\]. Both single-use and reusable bronchoscopes are suitable for this procedure \[[@CR1]\]. Single-use bronchoscopes are disposed of after the procedure, whereas reusable devices require cleaning, decontamination, sterilisation and sterile storage, with further re-sterilisation determined by the duration of storage. To estimate the cost per use for reusable bronchoscopes, the acquisition cost must be spread over the equipment's useful lifetime (which is not known in advance) and costs associated with reprocessing, storage and repair must be included. Many reusable devices also require a separate light source, an image capture, and display system, although these can be shared between multiple devices. Bronchoscopes may be damaged during PDT procedures, in which a needle is inserted in close proximity to the device \[[@CR1]\]. One hospital reported six perforations of reusable bronchoscopes occurring during 42 PDT procedures from January 2007 to November 2010, leading to a total cost of repair of around \$US10,700 \[[@CR10]\]. Perbet et al. estimated the repair costs of bronchoscopes damaged by PDT to be \$US475 per use (based on 76 PDT procedures from August 2009 to July 2014) \[[@CR11]\]. Bronchoscopes can also be damaged during other procedures or by handling, processing or storage. The repair cost following bronchoalveolar lavage (BAL) procedures has been reported to be \$US57 (based on 381 BAL procedures) \[[@CR11]\].

The cost per use for single-use bronchoscopes is the actual acquisition cost. Typically, prices for medical devices are likely to change over time due to the market entry of new products and innovation and may vary between countries and healthcare systems according to the way devices are procured (e.g. scale advantages) \[[@CR12]\].

The choice of single-use or reusable bronchoscopes for PDT is multifactorial, but cost is important to any organisation. Therefore, the aim of this study was to calculate the cost of use of single-use or reusable bronchoscopes per PDT procedure from a hospital perspective, based on the available literature, supplemented by questionnaire data from end users where necessary.

Methods {#Sec2}
=======

Literature Search {#Sec3}
-----------------

A systematic literature search, using a PICO approach, was conducted to identify articles assessing the cost of single-use and reusable bronchoscopes. Keyword searches were performed using the Cochrane database, PubMed, Embase, and Google Scholar, using search terms \[(bronchoscope OR bronchoscopes) AND cost AND (reusable OR single-use)\]. The search was limited to articles published from 1 January 2012 to 21 September 2017, since the first single-use bronchoscope was launched in 2012, and to human subjects. The systematic search was supplemented by an internet search using the Google search engine to identify posters and reports assessing the cost of bronchoscopes. A manual review of abstracts for the identified papers was carried out by AS and screened against the following inclusion criteria: articles assessing the cost of single-use or reusable bronchoscopes, and where costs were divided into acquisition, reprocessing and repair costs.

We coped with selection bias by using a structured method for the literature search (PICO), included grey literature, no language restriction and additional review of excluded and included literature by co-author AM.

For all included papers, a retrospective unit-cost approach was used, for example hospital register data, bronchoscope tracking systems and procedure flow data. Tvede et al. was the only study that included micro-costing via prospective time measurement for personal time spent on individual steps in the cleaning procedures \[[@CR13]\].

Procedures investigated were tube intubation for airway management, BAL, bronchoalveolar wash, difficult airway management, secretion management, and PDT procedures.

Acquisition cost and reprocessing cost per bronchoscope use were extracted for all included papers. The total cost associated with the reusable bronchoscopes, including all essential equipment, such as rack systems, light sources and image capture, was divided by the number of procedures, number of bronchoscopes available and the expected lifetime of the bronchoscope estimated in the studies. The cost of use of single-use bronchoscopes included the acquisition cost of the bronchoscope and the associated monitor, which was calculated according to the specific need for monitors per hospital. All costs were estimated in 2016 prices and the calculated costs were presented as means (standard deviations) in United States Dollars (\$US). Costs that were not obtained in 2016 prices were projected to 2016 values using the consumer price index from Trading Economics \[[@CR15]\]. Only costs that could be directly attributed to the use of bronchoscopes and costs that differed between single-use and reusable bronchoscopes were included. It was assumed that staffing and consumable costs related to conducting the procedure did not differ between devices.

Questionnaire {#Sec4}
-------------

In most studies included in the literature search, the cost calculations were based on BAL or unspecified procedures. To gather PDT-specific data, a questionnaire regarding repair rates and the costs of reusable bronchoscopes used for PDT was conducted to supplement the estimation from the literature. Due to scarce resources, western countries were selected. US, UK and Germany were selected as they represent the biggest markets for single-use bronchoscopes and collectively represent population majority \[[@CR14]\]. The questionnaire was sent to 366 hospitals in the US, UK and Germany that were known to perform PDT. The repair cost per bronchoscope use was calculated based on the total number of procedures, the total number of times the bronchoscopes had been damaged and the mean repair cost. A copy of the questionnaire is available in the Electronic Supplementary Material.

The mean repair cost per bronchoscope use for this study was calculated from questionnaire results and from Perbet et al. \[[@CR11]\] weighted by the number of procedures reported.

Sensitivity Analyses {#Sec5}
--------------------

Due to variance in cost estimations among the studies identified from the literature, and to make the data generalisable to other hospitals, two-way sensitivity analyses were conducted to test the relationship between the cost of reusable and single-use bronchoscopes in two different scenarios. For the first analysis, acquisition and reprocessing costs for reusable devices were pooled and set to \$US150, demonstrating a conservative approach. In the second analysis, acquisition and reprocessing costs were set to \$US207 as this is the accumulated mean when outliers are removed. For both analyses, the cost per repair was varied from \$US1000 to \$US6000 and the repair ratio was varied from 5 to 8%.

Furthermore, as the price for single-use bronchoscopes can vary between countries and depends on the number of bronchoscopes purchased, a one-way analysis was conducted. The price was adjusted from the lowest to the highest price from the studies identified in the literature (\$US208--322).

Results {#Sec6}
=======

A total of 422 articles were retrieved and abstracts were screened (Fig. [1](#Fig1){ref-type="fig"}). Seven articles were identified as relevant: six assessing the cost of both single-use and reusable bronchoscopes and one assessing the cost of reusable bronchoscopes only. Furthermore, four relevant posters were identified by an additional Google search.Fig. 1Study selection process

The mean cost per use of a reusable bronchoscope was estimated based on these 11 studies, describing 4476 procedures. The studies were from the US, UK, France and Denmark and were published between 2011 and 2017 (see Table [1](#Tab1){ref-type="table"}). The mean acquisition cost for a reusable bronchoscope was calculated to be \$US135 (SD 152) per use, with a mean reprocessing cost of \$US123 (SD 128) per use \[[@CR11], [@CR13], [@CR16]--[@CR24]\]. Based on 10 studies, the cost per use of a single-use bronchoscope was estimated to be \$US249 (SD 36) \[[@CR11], [@CR13], [@CR16]--[@CR19], [@CR21]--[@CR24]\].Table 1Details of the cost and usage of reusable and single-use bronchoscopes retrieved from the literatureAïssou et al. \[[@CR16]\]Bertrand et al. \[[@CR17]\]Debraine \[[@CR18]\]Gupta and Wang \[[@CR19]\]Liu et al. \[[@CR20]\]McCahon and Whynes \[[@CR21]\]Perbet et al. \[[@CR11]\]Sorli et al. \[[@CR22]\]Tvede et al. \[[@CR13]\]Videau et al. \[[@CR23]\]Wojcik et al. \[[@CR24]\]Mean (SD)Median (IQR)BALPDTReusable bronchoscope CountryFRFRFRUSUSUKFRFRDKFRFR SettingORORNAOROR/ICUOR/ICUICUNAOR/ICUNANA No. of scopes available2466914229122876 No. of procedures per year455328916611321417615171236060427373 (522)154 (116--193) Expected lifetime per scope (years)10521557554105NA86 Repair rate1:90NANA1:551:811:18NANANANANANA1:611:68 Acquisition cost (\$US)7419433231516893558258797557135 (152)77 (58--96) Reprocessing cost (\$US)13144224652206252531185764182123 (128)63 (47--79)Single-use bronchoscope Total cost per use (2016 \$US)222322257208NA261220222229284269249 (36)243 (182--304)*BAL* bronchoalveolar lavage, *DK* Denmark, *FR* France, *ICU* intensive care unit, *NA* not available, *OR* operating room, *PDT* percutaneous dilatational tracheostomy, *UK* United Kingdom, *US* United States

Ninety-nine completed responses were received from the 366 questionnaires (27% response rate). Of these, 31 hospitals used reusable equipment; 20 (64.5%) from the US, 8 (25.8%) from the UK and 3 (9.7%) from Germany, with a total annual number of 1698 PDT procedures performed. A repair ratio of 1:27 (corresponding to 3.7%) was associated with a mean repair cost of \$US3530 (SD 2669), giving a mean repair cost per PDT use of \$US133. The weighted mean repair cost following PDT from Perbet et al. \[[@CR11]\] and the questionnaires was calculated to be \$US148.

The total cost per use of a reusable bronchoscope for PDT was calculated to be \$US406 by combining acquisition, reprocessing and weighted mean repair costs. With the cost of a single-use bronchoscope estimated to be \$US249 per use, the incremental cost per use of a reusable bronchoscope compared with a single-use bronchoscope was \$US157. This equates to a 39% saving per PDT procedure for single-use bronchoscopes when compared with reusable bronchoscopes.

The two-way sensitivity analyses indicated potential cost savings in different scenarios for the reusable bronchoscopes for PDT. Using a conservative approach accumulating acquisition and reprocessing costs to \$US150, the use of reusable bronchoscopes results in cost savings when repair costs and repair rates are below \$US3530 and 3.7%, respectively.

The higher cost per repair and repair rate for reusable bronchoscopes made the single-use technology more advantageous (Fig. [2](#Fig2){ref-type="fig"}). The one-way sensitivity analysis using the range of identified purchase costs for single-use bronchoscopes demonstrated that single-use devices remained cheaper than reusable devices.Fig. 2Two-way sensitivity analyses: the red area indicates savings from using single-use bronchoscopes and the blue area indicates savings from using reusable bronchoscopes. Costs are in 2016 US dollars

Discussion {#Sec7}
==========

This study examined the average cost of bronchoscope use associated with PDT procedures using a combination of the available literature and questionnaires, finding that single-use devices were cheaper than reusable devices. These findings have implications for the procurement of bronchoscopes by hospitals and units that perform PDT. The two-way sensitivity analyses confirmed that the single-use device led to cost savings even in scenarios where several cost parameters for the reusable device were lowered.

Our study was the first to investigate in detail repair rates and associated costs for bronchoscopes specifically for PDT. The questionnaire data confirmed our prior assumptions that reusable bronchoscope repair rates were higher for PDT procedures than other bronchoscopy procedures. Four of the studies we identified reported repair rates for bronchoscopy procedures in general, with a pooled mean repair rate of 1 in 61 uses (Table [1](#Tab1){ref-type="table"}) \[[@CR16], [@CR19]--[@CR21]\]. This was significantly lower than the 1 in 27 repair rate for PDT procedures from the questionnaire. Furthermore, the repair cost per use for PDT identified in this study was higher than the repair cost for bronchoscopy procedures in general reported in the literature, perhaps reflecting more significant damage to reusable devices associated with the PDT procedure.

The identified studies revealed large differences in average costs per PDT for reusable bronchoscopes. One explanation for this could be a scale advantage (the negative associations identified between the number of annual procedures and reusable procedural costs) (Table [1](#Tab1){ref-type="table"}). Secondly, reprocessing of bronchoscopes is complex and time consuming. New US standards collectively recommend \> 100 steps for reprocessing each endoscope \[[@CR25]--[@CR29]\]. Only one study conducted accurate time measurements for personal time spent on reprocessing \[[@CR20]\]. Further, data from included studies are collected across countries and in different hospital settings, causing variance in reprocessing requirements, equipment acquisition costs, repair ratio and unit-costing method. For instance, in Australia and France reprocessing guidelines recommend re-cleaning of endoscopes if not used after 12 h, leading to a significant increase in costs \[[@CR30]\].

Thirdly, in several studies the economic calculations were inadequately described and therefore methodological differences cannot be excluded.

The previous studies only presented mean costs without dispersions and uncertainty measures. Thus, it was difficult to conduct meta-analyses on their results. In this study, we used the mean cost reported in the previous studies as this reflected the large variation in the annual number of procedures. Due to the variety of methodologies available to examine these figures, it could be argued that median values better reflect the 'typical' cost per use. This would eliminate the influence of the outliers and the cost of reusable bronchoscopes would be decreased. The median acquisition cost from the literature was \$US77 (15--558) and the median reprocessing cost was \$US63 (20--442). Together with the median repair cost estimated in this study (\$US129), the total cost per reusable bronchoscope calculated using median values was \$US269, while the median cost per use for single-use bronchoscopes was \$US243 \[[@CR11], [@CR13], [@CR16]--[@CR19], [@CR21]--[@CR24]\]. Thus, with median costs estimates, the incremental cost per use of a reusable bronchoscope compared with a single-use bronchoscope is \$US26. This is significantly lower in comparison with when mean values are used. A more ideal approach to estimate the true cost of use of reusable bronchoscopes would be to make a micro-costing analysis based on a suitable number of hospitals.

The majority of completed questionnaire responses are from the US, hence this can have an impact on average repair cost, since the US is known to have higher healthcare expenses \[[@CR31]\]. However, when calculating the individual mean from the US responses, it is in line with the German responses: \$US4275 and \$US4285, respectively. UK mean repair cost, on the other hand, appears significantly lower with \$US1757 per repair.

For single-use bronchoscopes, the scale advantage might also have an impact on the price because it is often possible to receive a discount when a large number of devices are purchased. Currently, there are only a few producers in the market manufacturing single-use devices. It is possible that more producers would increase competition in the market and that the price would be reduced, consequently making the single-use devices even more advantageous.

There may also be additional advantages in using disposable equipment, which may also have direct or indirect cost implications, such as the elimination of bronchoscope cross-infections and immediate availability in an emergency situation \[[@CR9], [@CR32], [@CR33]\]. A recent article by Terjesen et al. estimated additional costs associated with treatment of bronchoscope cross-infections to be \$US203 per procedure \[[@CR33]\].

The costs of the differences in time required to complete the procedure and number of personnel assisting per procedure have not been included in the study. The delivery and preparation of ancillary equipment to facilitate a reusable bronchoscopy have been shown to delay the start time of the procedure when compared with using single-use bronchoscopes \[[@CR32]\]. In contrast, the sensitivity analyses demonstrated scenarios where reusable bronchoscopes had the cost advantage; for example, when repair cost and repair ratio were below \$US3530 and 3.7%, respectively, in combination with acquisition and reprocessing costs equal to \$US150 per use or below.

The use of single-use bronchoscopes is associated with directly increased waste disposal and handling costs for the procedure. However, the waste cost for single-use bronchoscopes is estimated to be between \$US0.05 and \$US0.06 \[[@CR11], [@CR18]\]. Furthermore, the reprocessing of reusable bronchoscopes is associated with waste disposal such as single-use cleaning and protection equipment, disinfectants and chemical disposal. The cost of wage management has no impact on the conclusion.

Conclusion {#Sec8}
==========

Our study suggests that significant savings can be made by using single-use bronchoscopes to guide PDT in preference to reusable devices, and these findings may also be relevant for bronchoscope-guided procedures other than PDT. Further, we believe the findings are generalisable in Europe and the US. Finally, understanding institutional bronchoscope use and the associated costs in general and for PDT will enable an informed assessment of which approach represents better value for a particular unit or service.

Data Availability Statement {#FPar2}
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Acopy of the questionnaire, questionnaire results, and cost data is available in the Electronic Supplementary Material.

Electronic supplementary material
=================================
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Below is the link to the electronic supplementary material. Supplementary material 1 (ODS 16 kb) Supplementary material 2 (PDF 214 kb)
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